Forgot your password?
Indy, 20 mar 2013, 01:48:09 in Ekonomija i finansije
Znao sam ko će prvi da se javi
Vazan blog, uz par akademskih radova oko monopola poslodavca u odnosu na radnike - slucaj SAD.
By ALAN B. KRUEGER and ERIC POSNER FEB. 28, 2018
Cekajuci farmaceutski trickle down effect
One-shot cures for diseases are not great for business—more specifically, they’re bad for longterm profits—Goldman Sachs analysts noted in an April 10 report for biotech clients, first reported by CNBC.
The investment banks’ report, titled “The Genome Revolution,” asks clients the touchy question: “Is curing patients a sustainable business model?” The answer may be “no,” according to follow-up information provided.
You need to be a member in order to leave a comment
Sign up for a new account in our community. It's easy!
Already have an account? Sign in here.